Publications

September 26, 2019
Miro1 Marks Parkinson’s Disease Subset and Miro1 Reducer Rescues Neuron Loss in Parkinson’s Models
Chung-Han Hsieh, Li Li, Roeland Vanhauwaert, Kong T. Nguyen, Mary D. Davis, Guojun Bu, Zbigniew K. Wszolek, Xinnan Wang
October 5, 2018
Deep learning and virtual drug screening
Kristy A Carpenter, David S Cohen, Juliet T Jarrell & Xudong Huang
June 1, 2018
Machine Learning-based Virtual Screening and Its Applications to Alzheimer’s Drug Discovery: A Review
Kristy A. Carpenter and Xudong Huang
May 9, 2018
Most Ligand-Based Benchmarks Measure Overfitting Rather than Accuracy
Izhar Wallach, Abraham Heifets
October 10, 2015
Atomnet: A deep convolutional neural network for bioactivity prediction in structure-based drug discovery
Izhar Wallach, Michael Dzamba, Abraham Heifets
  1. Pages:
  2. 1
  3. 2